This grant application is for renewal of the Cancer Center Support Grant of the Vincent T. Lombardi Cancer Research Center. The Vincent T. Lombardi Cancer Research Center is an NCI-designated Comprehensive Cancer Center and is organized as a traditional matrix center. The current application represents a summary of cancer research activities conducted under the aegis of the cancer center. The application consists of 9 research programs: AIDS, Bone Marrow Transplantation and Experimental Immunology, Breast Cancer, Experimental Hematology/Lymphoma, Experimental Therapeutics, Growth Regulation of Cancer, Prostate Cancer, Invasion and Metastasis, and Radiation Oncology; 3 developing programs: Gynecologic Oncology, Psycho-Oncology, and Neuro-Oncology; and 10 core facilities: Data Systems, Animals, Biostatistics and Epidemiology, Clinical Research Management, Cytochemistry/ Morphology, Flow Cytometry, Synthesis/Sequencing, Tissue Culture, Tumor Bank, and 2-D Gel Electrophoresis. Since the previous application 3 years ago, there has been significant growth of the cancer center. This has been mirrored in an increase of the cancer center funded research base from $14,000,000 to $44,000,000; growth of the cancer center membership from 67 to 176. In the last 3 years there has also been very substantial success In competing for a Variety of program project grants and interdisciplinary grants including the awarding of a SPORE In Breast Cancer and AIDS Clinical Trials Unit to the Institution. The major focus of the cancer center continues to be the development of new methods of disease diagnosis, prognostication, prevention, and treatment based on an improved understanding of the cellular and molecular biology of human malignancy. The development of clinical and laboratory research in cancer is the highest stated priority of the Georgetown University Medical Center and is the object of the largest capital campaign ever conducted by Georgetown University.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
2P30CA051008-04
Application #
3101873
Study Section
Cancer Center Support Review Committee (CCS)
Project Start
1990-09-30
Project End
1997-04-30
Budget Start
1993-09-30
Budget End
1994-04-30
Support Year
4
Fiscal Year
1993
Total Cost
Indirect Cost
Name
Georgetown University
Department
Type
Schools of Medicine
DUNS #
049515844
City
Washington
State
DC
Country
United States
Zip Code
20057
Lee, Yichien; Rodriguez, Olga C; Albanese, Chris et al. (2018) Divergent brain changes in two audiogenic rat strains: A voxel-based morphometry and diffusion tensor imaging comparison of the genetically epilepsy prone rat (GEPR-3) and the Wistar Audiogenic Rat (WAR). Neurobiol Dis 111:80-90
Coia, Heidi; Ma, Ning; Hou, Yanqi et al. (2018) Prevention of Lipid Peroxidation-derived Cyclic DNA Adduct and Mutation in High-Fat Diet-induced Hepatocarcinogenesis by Theaphenon E. Cancer Prev Res (Phila) 11:665-676
Ory, Virginie; Kietzman, William B; Boeckelman, Jacob et al. (2018) The PPAR? agonist efatutazone delays invasive progression and induces differentiation of ductal carcinoma in situ. Breast Cancer Res Treat 169:47-57
Ozawa, Patricia Midori Murobushi; Alkhilaiwi, Faris; Cavalli, Iglenir João et al. (2018) Extracellular vesicles from triple-negative breast cancer cells promote proliferation and drug resistance in non-tumorigenic breast cells. Breast Cancer Res Treat 172:713-723
Smith, Jill P; Wang, Shangzi; Nadella, Sandeep et al. (2018) Cholecystokinin receptor antagonist alters pancreatic cancer microenvironment and increases efficacy of immune checkpoint antibody therapy in mice. Cancer Immunol Immunother 67:195-207
Edwardson, Matthew A; Zhong, Xiaogang; Fiandaca, Massimo S et al. (2018) Plasma microRNA markers of upper limb recovery following human stroke. Sci Rep 8:12558
Kaat, Aaron J; Schalet, Benjamin D; Rutsohn, Joshua et al. (2018) Physical function metric over measure: An illustration with the Patient-Reported Outcomes Measurement Information System (PROMIS) and the Functional Assessment of Cancer Therapy (FACT). Cancer 124:153-160
Maximov, Philipp Y; Abderrahman, Balkees; Fanning, Sean W et al. (2018) Endoxifen, 4-Hydroxytamoxifen and an Estrogenic Derivative Modulate Estrogen Receptor Complex Mediated Apoptosis in Breast Cancer. Mol Pharmacol 94:812-822
Czarnecka, Magdalena; Lu, Congyi; Pons, Jennifer et al. (2018) Neuropeptide Y receptor interactions regulate its mitogenic activity. Neuropeptides :
Gonzalez, Thomas L; Moos, Rebecca K; Gersch, Christina L et al. (2018) Metabolites of n-Butylparaben and iso-Butylparaben Exhibit Estrogenic Properties in MCF-7 and T47D Human Breast Cancer Cell Lines. Toxicol Sci 164:50-59

Showing the most recent 10 out of 1120 publications